Search Results for "HCTZ"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for HCTZ. Results 21 to 30 of 42 total matches.

Moexipril: Another ACE Inhibitor For Hypertension

   
The Medical Letter on Drugs and Therapeutics • Sep 01, 1995  (Issue 956)
COPYRIGHT LAWS 25 mg of hydrochlorothiazide (Hydrodiuril, and others) received in addition 3.75, 7.5 or 15 ...
Moexipril hydrochloride (Univasc - Schwarz Pharma), an angiotensin-converting enzyme (ACE) inhibitor, was recently approved by the US Food and Drug Administration (FDA) for treatment of. It is the eighth ACE inhibitor to be marketed in the USA.
Med Lett Drugs Ther. 1995 Sep 1;37(956):75-6 |  Show IntroductionHide Introduction

Candesartan for Hypertension

   
The Medical Letter on Drugs and Therapeutics • Nov 20, 1998  (Issue 1040)
, and others), digoxin (Lanoxin, and others), warfarin (Coumadin, and others) and hydrochlorothiazide (Esidrix ...
Candesartan cilexetil (Atacand - Astra) is the fourth angiotensin II receptor antagonist to become available in the USA for oral treatment of hypertension.
Med Lett Drugs Ther. 1998 Nov 20;40(1040):109-10 |  Show IntroductionHide Introduction

Initial Therapy of Hypertension

   
The Medical Letter on Drugs and Therapeutics • Jul 05, 2004  (Issue 1186)
hydrochlorothiazide or the ACE inhibitor enalapril (Vasotec, and others) were suggested for initial therapy ...
The importance of adequate control of hypertension in preventing organ damage and death is well established, but the choice of drugs is still controversial. Three recent drug trials, one supporting initial therapy with a diuretic, the second favoring an angiotensin converting enzyme (ACE) inhibitor, and the third showing equivalence between a calcium-channel blocker and an angiotensin-receptor blocker (ARB) have intensified the debate.
Med Lett Drugs Ther. 2004 Jul 5;46(1186):53-5 |  Show IntroductionHide Introduction

Nisoldipine-A New Calcium-Channel Blocker for Hypertension

   
The Medical Letter on Drugs and Therapeutics • Feb 16, 1996  (Issue 968)
mg are about as effective as hydrochlorothiazide (Esidrix, and others), lisinopril (Prinivil; Zestril ...
Nisoldipine (Sular -Zeneca), a dihydropyridine calcium-channel blocker structurally similar to nifedipine, has been approved for marketing by the US Food and Drug Administration. It is available in an oral extended-release formulation for treatment of hypertension.
Med Lett Drugs Ther. 1996 Feb 16;38(968):13-4 |  Show IntroductionHide Introduction

Sulfonamide Cross-Reactivity

   
The Medical Letter on Drugs and Therapeutics • Mar 25, 2019  (Issue 1568)
Thiazide and thiazide-like Chlorothiazide, chlorthalidone, diuretics hydrochlorothiazide, indapamide ...
A reader has questioned why the label for the COX-2 selective NSAID celecoxib (Celebrex, and generics), which contains a sulfonamide moiety, states that it is contraindicated for use in patients with an allergy to sulfonamides, while the labels of some other sulfonamide drugs recommend either caution or no precautions at all. The concept of cross-reactivity among sulfonamide drugs, particularly between antibacterial and nonantibacterial sulfonamides, has been controversial for many years.
Med Lett Drugs Ther. 2019 Mar 25;61(1568):44-6 |  Show IntroductionHide Introduction

In Brief: Aliskiren Trial Terminated

   
The Medical Letter on Drugs and Therapeutics • Jan 23, 2012  (Issue 1382)
Aliskiren is available alone (Tekturna) and in fixed-dose combinations with hydrochlorothiazide (Tekturna ...
A randomized, placebo-controlled trial evaluating the addition of the direct renin inhibitor aliskiren (Tekturna – Novartis) to an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) in 8606 patients with type 2 diabetes and renal impairment (ALTITUDE) was terminated prematurely by the manufacturer because the combined incidence of cardiovascular and renal events was higher in patients who received aliskiren than in those who received placebo.1Combining two different types of drugs that block the renin angiotensin system in patients at high-risk for...
Med Lett Drugs Ther. 2012 Jan 23;54(1382):5 |  Show IntroductionHide Introduction

Nicardipine - A New Calcium-Entry Blocker

   
The Medical Letter on Drugs and Therapeutics • May 05, 1989  (Issue 791)
). Nicardipine (30 mg tid) was at least as effective for mild to moderate hypertension as hydrochlorothiazide 25 ...
Nicardipine (Cardene - Syntex), a dihydropyridine calcium-entry blocker structurally related to nifedipine (Procardia; Adalat), was recently approved by the US Food and Drug Administration for oral treatment of angina and hypertension. Advertisements for the drug claim that nicardipine is more vasoselective; than other calcium-channel blockers and does not depress myocardial contractility.
Med Lett Drugs Ther. 1989 May 5;31(791):41-2 |  Show IntroductionHide Introduction

Fluconazole

   
The Medical Letter on Drugs and Therapeutics • May 18, 1990  (Issue 818)
may decrease serum concentrations of fluconazole, while hydrochlorothiazide may increase them. DOSAGE ...
Fluconazole (Diflucan - Roerig), an antifungal azole, was recently approved by the US Food and Drug Administration for oral and intravenous (IV) treatment of cryptococcal meningitis and various forms of candidiasis. Both cryptococcal meningitis and candidiasis occur frequently in patients with AIDS, organ transplants, or cancer.
Med Lett Drugs Ther. 1990 May 18;32(818):50-2 |  Show IntroductionHide Introduction

A New Ace Inhibitor and Two New Angiotensin Receptor Blockers For Hypertension

   
The Medical Letter on Drugs and Therapeutics • Nov 05, 1999  (Issue 1065)
in about 200 patients with mild-to-moderate hypertension not well controlled by hydrochlorothiazide ...
Perindopril, the tenth angiotensin converting enzyme (ACE) inhibitor to be marketed in the USA, and telmisartan and eprosartan, the fifth and sixth angiotensin receptor blockers, have recently become available for treatment of hypertension.
Med Lett Drugs Ther. 1999 Nov 5;41(1065):105-6 |  Show IntroductionHide Introduction

Olmesartan (Benicar) for hypertension

   
The Medical Letter on Drugs and Therapeutics • Aug 05, 2002  (Issue 1136)
hydrochlorothiazide (Esidrix, and others) in reducing diastolic blood pressure in patients with mild-to-moderate ...
Olmesartan medoxomil (Benicar - Sankyo), a substituted imidazole, is the seventh oral angiotensin II receptor blocker (ARB) approved by the FDA for treatment of hypertension.
Med Lett Drugs Ther. 2002 Aug 5;44(1136):69-70 |  Show IntroductionHide Introduction